Hoppa till innehåll
  • Home
  • Heart Failure
  • R&D
  • About us
  • News
  • Contact
Meny
  • Home
  • Heart Failure
  • R&D
  • About us
  • News
  • Contact
Get in touch

Dag: 4 april 2024

AnaCardio selected as finalist at the J.P. Morgan Asset Management: Life Sciences Innovation  Summit 

Stockholm, Sweden, April 4 , 2024 AnaCardio, a Swedish clinical-stage biopharmaceutical company focused on developing novel  contractile agents to treat patients with heart failure, announced today that it has been selected  as one of 11 finalists to present at the inaugural J.P. Morgan Asset Management: Life Sciences  Innovation Summit. The summit will take place on […]

Linkedin

Pages

  • Home
  • Heart Failure
  • R&D
  • About us
  • News
  • Contact

Contact us

  • A Working Lab Innomedicum
  • Nanna Svartz väg 4
  • 171 65 Solna
  • Stockholm, Sweden
  • Privacy Policy
  • © Copyright 2025